Dr Shefali Parikh

Dr. Shefali R Parikh has done her masters in ophthalmology from Patiala Medical College, Punjab. After finishing her residency, she did her specialization in glaucoma from world-renowned L. V. Prasad Eye Institute, Hyderabad. Subsequently, she went to Lund University, Sweden for her advance glaucoma fellowship. After coming back from Sweden in 2003, she joined L. V. Prasad Eye Institute, Hyderabad as a faculty where she worked for nearly 2 years. Subsequently, she worked in Sadhuram Lions Eye Hospital as a senior consultant. After coming back to Mumbai in 2008, she joined Lotus Eye Hospital and started glaucoma department. She worked in Lotus Eye Hospital as head, department of glaucoma for 4 years. Along with Dr. Rajul Parikh, she fulfilled her long-cherished desire of starting a tertiary care center for glaucoma in Mumbai in December 2010. Shreeji Eye Clinic & Palak’s Glaucoma Care Centre is a hi-tech, fully equipped, state of the art glaucoma care centre located in the heart of the city: andheri. Shreeji eye clinic & palak’s glaucoma care centre is progressing under her able guidance as chairperson & medical director. Her main areas of interest are glaucoma and anterior segment. She has vast surgical experience. She has performed more than 2000 glaucoma surgeries like trabeculetomy, phaco-trabeculectomy, trabeculectomy with small incision cataract surgery, advanced glaucoma surgeries like glaucoma valve implant surgeries, anterior segment reconstruction. She has also performed congenital glaucoma surgeries including surgeries in patients with axenfield - rieger syndrome, aniridia, nanophthalmos. She has performed numerous laser procedures like laser iridotomy, laser irioplasty, and laser suturolysis. She also has expertise in advanced cataract surgeries like phacoemulsification, small incision cataract surgery. She has performed more than 6000 cataract surgeries and was trainer for phacoemulsification at L V Prasad Eye Institute. She has been principal investigator / co-investigator for various clinical trials.